Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
This Breakthrough Therapy Designation highlights the impressive clinical benefit of Enhertu over the current standard of care
The study focused on patients without actionable genomic alterations whose disease had progressed after prior immunotherapy and platinum-based chemotherapy
Xeureka will receive an upfront payment from UBE and will be eligible for milestone payments tied to future research progress
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
The initiative is focused on a problem that continues to plague cancer outcomes in India
The move strengthens GBL’s clinical-stage presence in the United States
Subscribe To Our Newsletter & Stay Updated
